Monash University

New antibiotic to combat deadly bacterial 'superbugs' enters clinical trials
on June 18, 2021 at 7:04 am
In a critical step toward addressing an urgent unmet medical need due to infections caused by antibiotic-resistant bacteria—also known as superbugs—a new antibiotic (QPX9003) discovered by Monash ...
Monash University’s new antibiotic against superbugs starts US trial
on June 18, 2021 at 4:04 am
Researchers at Monash University in Australia have announced a Phase I clinical trial of a new antibiotic, QPX9003, to treat infections by antibiotic-resistant bacteria or superbugs in the US.
Unpaid Caregivers Were Already Struggling. It's Only Gotten Worse During The Pandemic
on June 17, 2021 at 5:00 pm
A new CDC study finds that people who provide unpaid care for their children or adult loved ones are twice as likely as noncaregivers to have experienced depression or anxiety, or thoughts of suicide.
Qpex Biopharma Initiates Phase 1 Study of QPX9003 Targeting Antibiotic-Resistant Pathogens
on June 17, 2021 at 5:00 am
Qpex Biopharma, Inc., (Qpex) a resistance-focused clinical-stage biopharmaceutical company discovering and developing innovative anti-infective therapies, announced initiation of a Phase 1 study of ...
Total Artificial Heart to be commercialised by Monash and BiVACOR
on June 16, 2021 at 5:09 pm
Monash University and BiVACOR, among others, have received $1M in federal government funding to develop and commercialise a durable Total Artificial Heart.

The Latest Google Headlines on:

Monash University Research

The Latest Bing News on:

Monash University Discovery

New antibiotic to combat deadly bacterial 'superbugs' enters clinical trials
on June 18, 2021 at 7:04 am
In a critical step toward addressing an urgent unmet medical need due to infections caused by antibiotic-resistant bacteria—also known as superbugs—a new antibiotic (QPX9003) discovered by Monash ...
Monash University’s new antibiotic against superbugs starts US trial
on June 18, 2021 at 4:04 am
Researchers at Monash University in Australia have announced a Phase I clinical trial of a new antibiotic, QPX9003, to treat infections by antibiotic-resistant bacteria or superbugs in the US.
Qpex Biopharma Initiates Phase 1 Study of QPX9003 Targeting Antibiotic-Resistant Pathogens
on June 17, 2021 at 5:00 am
Qpex Biopharma, Inc., (Qpex) a resistance-focused clinical-stage biopharmaceutical company discovering and developing innovative anti-infective therapies, announced initiation of a Phase 1 study of ...
New research shines light on perovskite solar cell performance
on June 14, 2021 at 10:47 am
The potential of a class of materials called perovskites, to enable solar cells to better absorb sunlight for energy production, is widely known. However, this potential has yet to be fully realized, ...
Monash University researcher receives prestigious Clunies Ross Award
on June 11, 2021 at 7:47 pm
Monash University Professor Jonathan Baell is among a team of Melbourne scientists that has been awarded the Australian Academy of Technology and Engineering (ATSE) Clunies Ross Award for Knowledge ...